Vijaya Diagnostic Centre Limited (VIJAYA) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹1,480 (+0.91% day change)
Key ratios
- P/E ratio
- 88.04
- P/B ratio
- 9.26
- ROE (%)
- 18.07
- ROCE (%)
- 17.72
- Debt/Equity
- 0.44
- Dividend yield (%)
- 0.23
- Market cap (₹ Cr)
- 15,243.66
Forensic checks
Piotroski F-Score: 7/9 · Altman Z-Score: 8.9 · Beneish M-Score: -2.32
InvestSights quality score
68.1/100 — Above Average (descriptive data-driven composite; not a recommendation)
Management guidance track record
- EBITDA margin: guided 40%, delivered 40.1% (FY25) — exceeded guidance
- Revenue growth: guided 15% YoY, delivered 19.57% YoY (FY26) — exceeded guidance
Latest earnings call (Q2 FY27)
AI summary: The most important signal is that Q2 growth was driven substantially by higher throughput at existing centres, especially in Hyderabad, rather than merely by network additions. Consolidated revenue grew 26.7%, existing centres grew 20%, and management confirmed that Hyderabad’s existing facilities are delivering higher growth despite the cluster already having close to 100…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.